Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-28

Clinical Trial Update: Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy [Phase 2]

View source ↗

Summary

Phase 2 trial update on oral immunotherapy for desensitization in children, adolescents, and young adults with hen egg allergy; study terminated with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aimmune Therapeutics, Inc. oral immunotherapy for hen egg allergy

Snippet

Sponsor: Aimmune Therapeutics, Inc. | Conditions: Hen Egg Allergy | Phase 2 | Status: TERMINATED | Results posted: 2022-02-28